Thousands of stories

Efavirenz (brand names Sustiva and Stocrin) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) and is used as part of highly active antiretroviral therapy (HAART) for the treatment of a human immunodeficiency virus (HIV) type 1.

For HIV infection that has not previously been treated, the United States Department of Health and Human Services Panel on Antiretroviral Guidelines currently recommends the use of efavirenz in combination with lamivudine/zidovudine (Combivir) or tenofovir/emtricitabine (Truvada) as the preferred NNRTI-based regimens in adults and adolescents.

Efavirenz is also used in combination with other antiretroviral agents as part of an expanded postexposure prophylaxis regimen to prevent HIV transmission for those exposed to materials associated with a high risk for HIV transmission.

The usual adult dose is 600 mg once a day. It is usually taken on an empty stomach at bedtime to reduce neurological and psychiatric adverse effects.

Efavirenz was combined with the popular HIV medication Truvada, which consists of tenofovir and emtricitabine, all of which are reverse transcriptase inhibitors. This combination of three medications approved by the U.S. Food and Drug Administration (FDA) in July 2006 under the brand name Atripla, provides HAART in a single tablet taken once a day. It results in a simplified drug regimen for many patients.

More on Wikipedia

Brand name: Sustiva
Generic name/category: Efavirenz, Non-nucleoside reverse transcriptase inhibitors, Alkynes, World Health Organization essential medicines
Company: Bristol-Myers Squibb BMS
Country/Market: USA, North America
Indication(s)/use: HIV combination therapy
Target: Healthcare Professionals (HCP)
Tagline: Thousands of stories
Medium: Web banner
Size/duration: 728X90
Publication/Aired: www.infectiousdiseasenews.com – September 2009
0 views
Sep 03, 2009

Visit AdPharm.net for more pharmaceutical ads

Print Executions

Chaque fois que vous couchez avec quelqu’un, vous couchez aussi avec son passé.

VIH: Faites-vous tester
etesvousarisque.ca

Every time you have sex with someone, you’re also having sex with their past.

HIV: Get tested

Web Banners

One life

To find out if you’re at risk for HIV, click here.

Every time you sleep with someone, you’re also sleeping with his past.

Agency: BleuBlancRouge
Creative Director: Dominique Trudeau
Art Director: Sébastien Deland
Copywriter: Guillaume Blanchet
Agency Producer (print): Lisa Arduini
Photographer (Print): Alain Desjean
Agency Producer (Web): Annie-Luce Hynes, Marie-Claude Roy
Flash developer: Bob Mainguy

Brand name: Une Vie / One Life
Generic name/category: Public service
Company: Bristol-Myers Squibb (BMS)
Country/Market: Canada, North America
Indication(s)/use: HIV, Disease awareness
Target: Consumers (DTC)
Tagline: Chaque fois que vous couchez avec quelqu’un, vous couchez aussi avec son passé.
Every time you have sex with someone, you’re also having sex with their past.
Publication: 2009
Source: AMPQ

the Italian info organisation fighting Aids/HIV

HIV
It could happen to everyone, don’t discriminate.

Art Director/Copywriter: Andrea Castelletti
Photographer: Matteo Engolli.

Generic name/category: Disease awareness, public service
Company: LILA (Lega Italiana per la Lotta contro l’Aids)
Country/Market: Italy, Europe
Indication(s)/use: HIV, AIDS
Target: Consumers (DTC)
Publication: 2009

Wake up Pune.
You can make a difference
Take the lead. Join the ‘Bindi campaign’
www.wakeuppune.org

Sport the Red Bindi on 1st December. Support the HIV cause. Wake up Pune.

Agency: Mercury
Copywriter: Sanju Ayyar
Art director: Shailesh Meshram
Photographer: Abhijeet Gujar
2008

More public service ads on AdPharm

Great body

Body Parts

Doctor

SOA Aids Nederland
Product: Safe Sex Campaign 2008
Agency: VANABBETOTVESSEM Amsterdam
DoP: Lex Brand
Editor: Annelien van Wijnbergen
Creatives: Berend Boorsma, Ronald van Vessem, Michiel van Abbe
Agency Producer: Artcore Productions B.V.
Producer: Stefany Rietkerk & Jan Koopmans
Director: Berend Boorsma
Production Company: Artcore Productions B.V.
Country: Netherlands

Patient advocates are complaining that GlaxoSmithKline is using scary advertising to market medicines for HIV, the deadly virus that causes AIDS.

One Glaxo ad shows shark-infested waters with the message: Don’t take a chance‚ stick with the HIV medicine that’s working for you. Some of Glaxo’s biggest HIV drugs have been losing ground to newer treatments, and AIDS groups say the ads appear aimed at dissuading patients from abandoning Glaxo drugs for others, according to this morning’s WSJ.

To read this story, go to: http://blogs.wsj.com/health/2008/08/25/are-ads-for-hiv-drugs-too-scary/

The pharmaceutical company Bristol-Myers Squibb and Universal Music have joined forces to launch the campaign Luvu2.ca designed to encourage young people to take tests for detecting HIV.

Designed and produced by Bleublancrouge and its pharmaceutical division BBRx, the operation unveiled on August 18 counts on the popularity of the group U2 and singer Mary J. Blige to attract the attention of youth.

One Life (Life) target sexually active young people of 18-30 years, and invites them to use contraception and passing detection tests for HIV. The initiative is based on a video aired free of the song “One” by U2 and recorded by Mary J. Blige.

Hoping to generate excitement on the Internet through forums and blogs, the two firms will give $ 1 to groups of HIV-AIDS whenever the video is downloaded.

Client: Bristol-Myers Squibb
Agency: Bleublancrouge
Account Servicing: Michel Vézina, Rita de Marco, Nancy Bouzi
Creative: Éric Capel
Photo: Valérie Simmons
Director: Thomas Castaing
Agency Producers: Normand Vaillancourt, Lisa Arduini, Dominique Dufour
Production House: De Shed - Renaud Côté
Special Effects and 3D: De Shed - Sylvain Lebeau

Original post on InfoPresse.com